Skip to main content

Processa Pharmaceuticals, Inc PRE 14A, filed Oct 9, 2026

Processa Pharmaceuticals, Inc. (PCSA)

Processa Pharmaceuticals completed its merger with Vidya Therapeutics on July 28, 2026 and raised approximately $200 million; stockholders will vote on required Nasdaq issuances and equity plans. AI summary

PRE 14A 2026-10-09 For: 2026-10-09
View Original
Added on October 18, 2026